epinastine has been researched along with olopatadine hydrochloride in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 13 (76.47) | 29.6817 |
| 2010's | 4 (23.53) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| D'Arienzo, P; Epstein, AB; Finegold, I; Granet, D; Lanier, BQ; Ledgerwood, GL | 1 |
| Izu, K; Tokura, Y | 1 |
| Inoue, T; Kamei, C; Rahman, MA | 1 |
| Farley, W; Pflugfelder, SC; Villareal, AL | 1 |
| D'Arienzo, PA; Epstein, AB; Finegold, I; Granet, DB | 1 |
| Chuck, RS; Combs, JC; Lekhanont, K; Park, CY; Rangsin, R; Suwan-Apichon, O | 1 |
| Bensch, G; Greiner, JV; Mah, FS; Rosenwasser, LJ; Townsend, WD | 1 |
| Beauregard, C; Gamache, D; Roberts, L; Stephens, D; Yanni, J | 1 |
| Ajayi, Y; Calder, VL; Galatowicz, G; Stern, ME | 1 |
| Fukui, H; Izumi, N; Mizuguchi, H; Ogino, S; Umehara, H | 1 |
| Akman, A; Akova, YA; Borazan, M; Erbek, SS; Karalezli, A; Kiyici, H | 1 |
| Fukui, H; Hatano, M; Kitamura, Y; Kuroda, W; Matsushita, C; Mizuguchi, H; Takeda, N; Umehara, H | 1 |
| Bonini, S; Lambiase, A; Micera, A | 1 |
| Fujishima, H; Ohashi, Y; Takamura, E | 1 |
| Ebihara, N; Fukushima, A | 1 |
| Chen, LJ; Kam, KW; Wat, N; Young, AL | 1 |
| Ben-Eli, H; Solomon, A | 1 |
3 review(s) available for epinastine and olopatadine hydrochloride
| Article | Year |
|---|---|
Multiple action agents and the eye: do they really stabilize mast cells?
Topics: Animals; Anti-Inflammatory Agents; Arachidonic Acid; Conjunctivitis, Allergic; Cytokines; Dibenzazepines; Dibenzoxepins; Histamine; Histamine Antagonists; Humans; Imidazoles; Immunity, Innate; Ketotifen; Mast Cells; Olopatadine Hydrochloride; Phthalazines | 2009 |
Topical Olopatadine in the Treatment of Allergic Conjunctivitis: A Systematic Review and Meta-analysis.
Topics: Administration, Ophthalmic; Anti-Allergic Agents; Benzazepines; Conjunctivitis, Allergic; Dibenzazepines; Histamine H1 Antagonists; Humans; Imidazoles; Ketotifen; Olopatadine Hydrochloride; Ophthalmic Solutions; Treatment Outcome | 2017 |
Topical antihistamines, mast cell stabilizers, and dual-action agents in ocular allergy: current trends.
Topics: Administration, Ophthalmic; Anti-Allergic Agents; Benzazepines; Conjunctivitis, Allergic; Cromolyn Sodium; Dibenzazepines; Histamine Antagonists; Humans; Hyperemia; Imidazoles; Ketotifen; Nedocromil; Olopatadine Hydrochloride; Phthalazines; Piperidines; Pruritus; Pyridines; Pyrimidinones | 2018 |
6 trial(s) available for epinastine and olopatadine hydrochloride
| Article | Year |
|---|---|
Clinical efficacy of olopatadine vs epinastine ophthalmic solution in the conjunctival allergen challenge model.
Topics: Administration, Topical; Adult; Allergens; Anti-Allergic Agents; Conjunctivitis, Allergic; Diagnostic Techniques, Ophthalmological; Dibenzazepines; Dibenzoxepins; Double-Blind Method; Female; Humans; Imidazoles; Male; Models, Biological; Olopatadine Hydrochloride; Ophthalmic Solutions; Prospective Studies; Treatment Outcome | 2004 |
Efficacy and response with olopatadine versus epinastine in ocular allergic symptoms: a post hoc analysis of data from a conjunctival allergen challenge study.
Topics: Adult; Aged; Dibenzazepines; Dibenzoxepins; Eye Diseases; Female; Humans; Hypersensitivity; Imidazoles; Male; Middle Aged; Olopatadine Hydrochloride; Placebos; Treatment Outcome | 2006 |
Efficacy and comfort of olopatadine 0.2% versus epinastine 0.05% ophthalmic solution for treating itching and redness induced by conjunctival allergen challenge.
Topics: Adolescent; Adult; Aged; Allergens; Color; Conjunctivitis, Allergic; Dibenzazepines; Dibenzoxepins; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Imidazoles; Male; Middle Aged; Olopatadine Hydrochloride; Ophthalmic Solutions; Patient Satisfaction; Placebos; Pruritus; Treatment Outcome | 2007 |
Efficacy of olopatadine HCI 0.1%, ketotifen fumarate 0.025%, epinastine HCI 0.05%, emedastine 0.05% and fluorometholone acetate 0.1% ophthalmic solutions for seasonal allergic conjunctivitis: a placebo-controlled environmental trial.
Topics: Adolescent; Adult; Anti-Allergic Agents; Benzimidazoles; Child; Conjunctival Diseases; Conjunctivitis, Allergic; Dibenzazepines; Dibenzoxepins; Double-Blind Method; Edema; Eyelid Diseases; Female; Fluorometholone; Histamine H1 Antagonists; Humans; Imidazoles; Ketotifen; Male; Middle Aged; Olopatadine Hydrochloride; Ophthalmic Solutions; Prospective Studies; Pruritus; Seasons; Tears; Treatment Outcome; Young Adult | 2009 |
Efficacy of epinastine hydrochloride ophthalmic solution in allergic conjunctivitis by conjunctival cedar pollen allergen challenge.
Topics: Adult; Allergens; Anti-Allergic Agents; Cedrus; Conjunctiva; Conjunctivitis, Allergic; Dibenzazepines; Dibenzoxepins; Female; Histamine H1 Antagonists; Humans; Hyperemia; Imidazoles; Male; Middle Aged; Olopatadine Hydrochloride; Ophthalmic Solutions; Platelet Aggregation Inhibitors; Pollen; Rhinitis, Allergic, Seasonal; Young Adult | 2014 |
Efficacy of olopatadine versus epinastine for treating allergic conjunctivitis caused by Japanese cedar pollen: a double-blind randomized controlled trial.
Topics: Adult; Allergens; Anti-Allergic Agents; Conjunctivitis, Allergic; Cryptomeria; Dibenzazepines; Double-Blind Method; Female; Humans; Imidazoles; Japan; Male; Olopatadine Hydrochloride; Ophthalmic Solutions; Pollen; Severity of Illness Index; Skin Tests; Treatment Outcome | 2014 |
8 other study(ies) available for epinastine and olopatadine hydrochloride
| Article | Year |
|---|---|
The various effects of four H1-antagonists on serum substance P levels in patients with atopic dermatitis.
Topics: Adult; Anti-Allergic Agents; Cetirizine; Dermatitis, Atopic; Dibenzazepines; Dibenzoxepins; E-Selectin; Female; Histamine H1 Antagonists; Humans; Imidazoles; Intercellular Adhesion Molecule-1; Male; Olopatadine Hydrochloride; Substance P; Terfenadine; Vascular Cell Adhesion Molecule-1 | 2005 |
Role of substance P in allergic nasal symptoms in rats.
Topics: Animals; Antigens; Cyproheptadine; Dibenzazepines; Dibenzoxepins; Dose-Response Relationship, Drug; Electroencephalography; Histamine H1 Antagonists; Hypersensitivity; Imidazoles; Male; Neurokinin-1 Receptor Antagonists; Olopatadine Hydrochloride; Rats; Rats, Wistar; Sneezing; Substance P; Tryptophan | 2006 |
Effect of topical ophthalmic epinastine and olopatadine on tear volume in mice.
Topics: Administration, Topical; Animals; Conjunctivitis, Allergic; Dibenzazepines; Dibenzoxepins; Female; Histamine H1 Antagonists; Histamine H1 Antagonists, Non-Sedating; Imidazoles; Lacrimal Apparatus; Male; Mice; Mice, Inbred C57BL; Olopatadine Hydrochloride; Ophthalmic Solutions; Tears | 2006 |
Effect of topical olopatadine and epinastine in the botulinum toxin B-induced mouse model of dry eye.
Topics: Administration, Topical; Animals; Botulinum Toxins; Botulinum Toxins, Type A; Dibenzazepines; Dibenzoxepins; Disease Models, Animal; Female; Histamine H1 Antagonists; Imidazoles; Keratoconjunctivitis Sicca; Mice; Mice, Inbred CBA; Olopatadine Hydrochloride; Tears | 2007 |
Duration of action of topical antiallergy drugs in a Guinea pig model of histamine-induced conjunctival vascular permeability.
Topics: Administration, Topical; Animals; Anti-Allergic Agents; Capillary Permeability; Conjunctiva; Delayed-Action Preparations; Dibenzazepines; Dibenzoxepins; Dose-Response Relationship, Drug; Guinea Pigs; Histamine; Histamine H1 Antagonists; Imidazoles; Ketotifen; Male; Olopatadine Hydrochloride; Ophthalmic Solutions; Phthalazines | 2007 |
Ocular anti-allergic compounds selectively inhibit human mast cell cytokines in vitro and conjunctival cell infiltration in vivo.
Topics: Animals; Anti-Allergic Agents; Cell Differentiation; Cell Movement; Cells, Cultured; Conjunctiva; Conjunctivitis, Allergic; Cytokines; Dibenzazepines; Dibenzoxepins; Eosinophilia; Female; Fetal Blood; Histamine Release; Humans; Imidazoles; Mast Cells; Mice; Mice, Inbred BALB C; Nedocromil; Neutrophils; Olopatadine Hydrochloride; Pollen; Proto-Oncogene Proteins c-kit; Receptors, IgE; Stem Cells | 2007 |
Analysis of disease-dependent sedative profiles of H(1)-antihistamines by large-scale surveillance using the visual analog scale.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Asthma; Butyrophenones; Cetirizine; Child; Chlorpheniramine; Dermatitis, Atopic; Dibenzazepines; Dibenzoxepins; Female; Histamine H1 Antagonists; Histamine H1 Antagonists, Non-Sedating; Humans; Imidazoles; Japan; Male; Middle Aged; Olopatadine Hydrochloride; Pain Measurement; Piperidines; Population Surveillance; Psychomotor Performance; Pyridines; Quality of Life; Rhinitis, Allergic, Perennial; Rhinitis, Allergic, Seasonal; Sleep Stages; Surveys and Questionnaires; Terfenadine; Urticaria | 2008 |
Repeated pre-treatment with antihistamines suppresses [corrected] transcriptional up-regulations of histamine H(1) receptor and interleukin-4 genes in toluene-2,4-diisocyanate-sensitized rats.
Topics: Animals; Chlorpheniramine; Dibenzazepines; Dibenzoxepins; Drug Administration Schedule; Histamine H1 Antagonists; Imidazoles; Interleukin-4; Male; Nasal Mucosa; Olopatadine Hydrochloride; Rats; Rats, Inbred BN; Receptors, Histamine H1; RNA, Messenger; Sneezing; Time Factors; Toluene 2,4-Diisocyanate; Transcription, Genetic; Up-Regulation | 2008 |